Table 2 Clinical characteristics of patients included.
Crohn's disease | Ulcerative colitis | |
|---|---|---|
Number | 68 | 24 |
Disease duration (months) | 27 (0-268) | 11 (1-188) |
Outpatients | 61 (90%) | 16 (67%) |
Previous hospitalizations | 2 (0-14) | 2 (0-6) |
Previous resective surgery | 33 (49%) | - |
Localization | ||
L1: Terminal ileum | 28 (41%) | |
L2: Colon | 21 (31%) | |
L3: Ileocolon | 15 (22%) | |
L4: Upper gastrointestinal | 4 (6%) | |
E1: Ulcerative proctitis | 2 (8%) | |
E2: Left-sided Ulcerative colitis | 7 (29%) | |
E3: Extensive Ulcerative colitis | 15 (63%) | |
Behavior | ||
B1: inflammatory | 27 (40%) | |
B2: stricturing | 26 (38%) | |
B3: penetrating | 15 (22%) | |
Perianal disease | 24 (35%) | 1 (4%) |
Indication of treatment | ||
Steroid dependence | 24 (35%) | 15 (62%) |
Induction of remission | 10 (15%) | 5 (21%) |
Maintenance after severe flare | 1 (1%) | 4 (17%) |
Fistulizing disease | 8 (12%) | - |
Prevention of recurrence | 21 (31%) | - |
Extensive disease | 4 (6%) | - |
Concomitant treatment | ||
Steroids | 35 (52%) | 17 (71%) |
Infliximab | 8 (12%) | - |
Antibiotics | 18 (27%) | 1 (4%) |
Mesalamine | 2 (3%) | 5 (21%) |
Topical treatment | 1 (2%) | 19 (79%) |